Citadel Advisors
AXLA

Citadel Advisors’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Citadel Advisors’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4
Closed -$33 – 15893
2022
Q4 		$33 Buy
+4
New +$104 ﹤0.01% 14797
2021
Q4 		– Sell
-924
Closed -$69K – 15122
2021
Q3 		$69K Buy
+924
New +$79.2K ﹤0.01% 13166

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

Citadel Advisors's AXLA Position: Q1 2023 in Review

Citadel Advisors sold out of Axcella Health Inc. Common Stock (AXLA) in Q1 2023, closing a stake of 713 shares — an estimated $5.84K sold.

Citadel Advisors first reported a position in AXLA in Q3 2021 and held it in 5 quarters. The position peaked at $75K in Q3 2021. 29 funds tracked by Wall St. Rank hold AXLA as of Q1 2023.

  • Citadel Advisors reported no remaining Axcella Health Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 713 Axcella Health Inc. Common Stock shares in Q1 2023, an estimated $5.84K.
  • Citadel Advisors first reported a position in Axcella Health Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Citadel Advisors's Axcella Health Inc. Common Stock position peaked at $75K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.